An interventional study of Nasr fascial closure device and Berci Fascial Closure Device in Cholecystolithiasis, sponsored by ClinAmygate. Recruiting at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-09-21.
Sponsored by ClinAmygate · Not applicable, Interventional, and Treatment
The study will investigate the efficacy and safety of a new fascial closure device "Nasr Fascial Closure Device" compared to the Karl Storz Berci Fascial Closure Device 26173AM.
88 studies on the registry are indexed under Cholecystolithiasis; 17 are open to participants now.
This study's planned enrollment of 160 is above the median of 100 across 59 interventional studies indexed under Cholecystolithiasis.
Browse Cholecystolithiasis studies →ClinAmygate is the lead sponsor of 18 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Device: Nasr fascial closure device
Device: Berci Fascial Closure Device
Nasr fascial closure device is a novel device for fascial closure
Berci Fascial Closure Device is a known device for fascial closure
duration of port site closure
Duration in seconds
Time frame: 1 day
Rate of failure of port site
Rate of failure to close the port site
Time frame: 1 day
Incidence of port site infection
Incidence of infection of the port site
Time frame: 1 month
Incidence of port site hernia
Incidence of hernia at the port site
Time frame: 6 weeks
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
ClinAmygate